# Intapp, Inc.: Form 10-Q for the period ended Mar 31, 2022

- Company: [Intapp, Inc.](/companies/inta.md) (CIK 1565687)
- Form: 10-Q
- Filed: 2022-05-13
- Accepted by EDGAR: May 13, 2022, 16:12 ET
- Period: 2022-03-31
- Accession: 0001564590-22-020122
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1565687/000156459022020122/inta-10q_20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1565687/000156459022020122/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $69.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2021-07-01 to 2022-03-31 | $196.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-01-01 to 2022-03-31 | $26.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2021-07-01 to 2022-03-31 | $71.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2022-01-01 to 2022-03-31 | $43.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2021-07-01 to 2022-03-31 | $124.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-01-01 to 2022-03-31 | $20.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2021-07-01 to 2022-03-31 | $54.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-01-01 to 2022-03-31 | −$28.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-07-01 to 2022-03-31 | −$76.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-01-01 to 2022-03-31 | $39.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2021-07-01 to 2022-03-31 | $236.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | −$271.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2021-07-01 to 2022-03-31 | −$990.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | −$28.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-07-01 to 2022-03-31 | −$78.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months, 2021-07-01 to 2022-03-31 | $4.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-07-01 to 2022-03-31 | $281.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2021-07-01 to 2022-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-03-31 | $42.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $120.5m | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $449.6m | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $181.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-03-31 | $192.1m | us-gaap:Liabilities |
| Long-term debt | at 2022-03-31 | $0 | us-gaap:LongTermDebt |
| Shareholders' equity | at 2022-03-31 | $257.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1565687/000156459022020122/inta-10q_20220331.htm

Filed May 13, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-020122. Last ingested by Listed: Nov 13, 2026, 15:20 ET. No prices; not investment advice.
